Position in NTRA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$404,379
-$59,299 QoQ
Shares Held
2,022
-0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Summit Financial, LLC holds $6,969,585 across 7 Diagnostics & Research names. NTRA ranks #7 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
3,555 | $1,747,389 | |
| 2 | GRAL |
GRAIL, Inc.
|
30,267 | $1,564,198 | |
| 3 | DHR |
Danaher Corp /De/
|
6,521 | $1,236,381 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
1,464 | $822,606 | |
| 5 | RDNT |
RadNet, Inc.
|
12,668 | $708,014 | |
| 6 | DGX |
Quest Diagnostics Inc
|
2,483 | $486,618 | |
| 7 | NTRA |
Natera, Inc.
This page
|
2,022 | $404,379 |
All Filings in NTRA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $404,379 | 2,022 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $463,678 | 2,024 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $890,486 | 5,532 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||